Vireo is in early access and completely free until 1 August 2026. Everyone who signs up before then keeps the founding-member price permanently: €3/month (normally €5).
Vireo
/

Karl Hård af Segerstad — Management

Roles

Egetis Therapeutics AB (publ) Stockholm
Management
27.11.2025 – 13.05.2026

Transactions (including via associated entities)

DateIssuerNatureVolumePriceValueSource
13.05.2026Egetis Therapeutics AB (publ) Stockholm
SoldDisposal
119,529SEK 6.50
SEK 776,938.50
↗
11.05.2026Egetis Therapeutics AB (publ) Stockholm
Share award
265,620—
Share award
265,620 shares
↗
28.11.2025Egetis Therapeutics AB (publ) Stockholm
Bought — open marketAcquisition
5,000SEK 4.86
SEK 24,300.00
↗
28.11.2025Egetis Therapeutics AB (publ) Stockholm
Bought — open marketAcquisition
25,000SEK 4.73
SEK 118,250.00
↗
28.11.2025Egetis Therapeutics AB (publ) Stockholm
Bought — open marketAcquisition
25,000SEK 4.79
SEK 119,750.00
↗
27.11.2025Egetis Therapeutics AB (publ) Stockholm
Bought — open marketAcquisition
25,000SEK 4.58
SEK 114,500.00
↗